SNPHF OTC
Santen Pharmaceutical Co., Ltd.
1W: +1.0%
1M: +0.0%
3M: +0.0%
YTD: +37.2%
1Y: +14.0%
3Y: +44.7%
5Y: -3.3%
$13.05
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$293B
Revenue
-2.3% YoY
$38B
Net Income
+3.7% YoY
$31B
Free Cash Flow
-42.8% YoY
61.4%
Gross Margin
21.1%
Op. Margin
19.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE12.8%
ROA9.0%
ROIC14.4%
Valuation
P/E13.8
P/B1.8
EV/EBITDA0.0
Leverage
Debt/Equity0.12
Current Ratio2.60
Interest Cov.33.6x
Quality Scores
Piotroski F7/9
Altman Z—
Beneish M-2.47